AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30351995 — intervention group
Group type: COMPARATOR
Intervention: Small-incision (2.75 mm)
Number of subjects: 67
Study 28045314 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP‐ACP paste (GC Tooth Mousse) applied at each monthly orthodontic follow‐up examination
Number of subjects: 57
Study 28045314 — intervention group
Group type: COMPARATOR
Intervention: Routine orthodontic treatment (control group)
Number of subjects: 57
Study 25590146 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling to caregivers and classroom health education interventions
Number of subjects: 65
Study 25590146 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 65
Study 23663810 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 980
Study 20215772 — intervention group
Group type: EXPERIMENTAL
Intervention: Biohormon (somatropin from transgenic cows)
Number of subjects: 24
Study 20215772 — intervention group
Group type: COMPARATOR
Intervention: HHT (somatropin from E. coli)
Number of subjects: 24
Study 18362870 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion XL (150 to 300 mg/day)
Number of subjects: 24
Study 18362870 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (10 to 20 mg/day)
Number of subjects: 24
Study 17050258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 30
Study 17050258 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (matched group)
Number of subjects: 30
Study 12725705 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 2 mg twice daily (R4 + SU)
Number of subjects: 530
Study 12725705 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg twice daily (R8 + SU)
Number of subjects: 530
Study 12725705 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SU + P)
Number of subjects: 530
Study 11221822 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 incentive
Number of subjects: 1800
Study 11221822 — intervention group
Group type: COMPARATOR
Intervention: $2 incentive
Number of subjects: 1800
Study 11221822 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up phone calls
Number of subjects: 1800
Study 9043007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg four times daily
Number of subjects: 452
Study 9043007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg four times daily
Number of subjects: 452
Study 9043007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg twice daily
Number of subjects: 452
Study 9043007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study 9043007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol groups
Number of subjects: 452
Study 9043007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 452
Study 21207909 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal approach video
Number of subjects: 0
Study 21207909 — intervention group
Group type: COMPARATOR
Intervention: Factual approach video
Number of subjects: 0
Study 3365580 — intervention group
Group type: EXPERIMENTAL
Intervention: CPSC data provided to medical personnel
Number of subjects: 4
Study 3365580 — intervention group
Group type: COMPARATOR
Intervention: No CPSC data provided to medical personnel
Number of subjects: 4
Study 29526707 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered DMPA-SC
Number of subjects: 731
Study 29526707 — intervention group
Group type: COMPARATOR
Intervention: Provider-administered DMPA-SC
Number of subjects: 731
Study 28062255 — intervention group
Group type: EXPERIMENTAL
Intervention: Bihemispheric tDCS (anodal over left temporal area and cathodal over right temporal area)
Number of subjects: 30
Study 28062255 — intervention group
Group type: EXPERIMENTAL
Intervention: Unihemispheric anodal tDCS over the left temporal area
Number of subjects: 30
Study 28062255 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 30
Study 25725185 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-massage
Number of subjects: 121
Study 25725185 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage alone
Number of subjects: 121
Study 25725185 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 121
Study 23377641 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention for anxiety disorders
Number of subjects: 287
Study 23377641 — intervention group
Group type: COMPARATOR
Intervention: Control group (higher-income participants)
Number of subjects: 287
Study 21471653 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 81
Study 17404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A: four doses of 20 ml 40% w/v barium sulphate
Number of subjects: 95
Study 17404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen B: three doses of 20 ml 40% w/v barium sulphate
Number of subjects: 95
Study 17404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen C: three doses of 20 ml 40% w/v barium sulphate plus 220 ml 2.1% barium sulphate
Number of subjects: 95
Study 17404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen D: three doses of 20 ml 40% w/v barium sulphate plus 15 ml diatriazoate megluamine
Number of subjects: 95
Study 17404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-laxative CTC
Number of subjects: 95
Study 16842476 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 130
Study 16842476 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 130
Study 14666441 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SN)
Number of subjects: 45
Study 14666441 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 45
Study 14666441 — intervention group
Group type: COMPARATOR
Intervention: Control (no hypotension)
Number of subjects: 45
Study 15470825 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threodops (200 mg orally 2 hours before each session) with physical therapy (PT) and occupational therapy (OT) for 2 months, 3 days a week.
Number of subjects: 13
Study 15470825 — intervention group
Group type: COMPARATOR
Intervention: Control group received PT and OT for 4 months without L-threodops.
Number of subjects: 13
Study 9509823 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus aerobic exercise program in a supervised group setting (Group B)
Number of subjects: 31
Study 9509823 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus weight training plus aerobic exercise program (Group D)
Number of subjects: 31
Study 9509823 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (Group A)
Number of subjects: 31
Study 9509823 — intervention group
Group type: COMPARATOR
Intervention: Diet plus weight training (Group C)
Number of subjects: 31
Study 29556709 — intervention group
Group type: EXPERIMENTAL
Intervention: 11+ injury prevention program (High Compliance, > 40 doses/season)
Number of subjects: 675
Study 29556709 — intervention group
Group type: EXPERIMENTAL
Intervention: 11+ injury prevention program (Moderate Compliance, 20-39 doses/season)
Number of subjects: 675
Study 29556709 — intervention group
Group type: EXPERIMENTAL
Intervention: 11+ injury prevention program (Low Compliance, 1-19 doses/season)
Number of subjects: 675
Study 29556709 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance as a continuous variable
Number of subjects: 675
Study 26476719 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (20 mg/10 ml)
Number of subjects: 45
Study 26476719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (50 mg + morphine 10 mg/10 ml)
Number of subjects: 45
Study 26476719 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9 % 10 ml)
Number of subjects: 45
Study 24852042 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab (various doses)
Number of subjects: 1047
Study 24852042 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 or 90 mg
Number of subjects: 1047
Study 24852042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047
Study 21870975 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG with surgical microscope
Number of subjects: 24
Study 21870975 — intervention group
Group type: COMPARATOR
Intervention: SCTG without surgical microscope
Number of subjects: 24
Study 19874691 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment + Glutamine 10g tid
Number of subjects: 60
Study 19874691 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 60
Study 16373408 — intervention group
Group type: EXPERIMENTAL
Intervention: Body temperature contrast medium
Number of subjects: 0
Study 16373408 — intervention group
Group type: COMPARATOR
Intervention: Room temperature contrast medium
Number of subjects: 0
Study 15373927 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (2 microg intravenous dose)
Number of subjects: 24
Study 11772354 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 0
Study 11772354 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of artemether and praziquantel
Number of subjects: 0
Study 9395279 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 809
Study 9395279 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 809
Study 7526096 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic-artery infusion of floxuridine
Number of subjects: 100
Study 7526096 — intervention group
Group type: COMPARATOR
Intervention: Conventional symptom palliation
Number of subjects: 100
Study 3662274 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 5 to 40 mg twice daily or 20 to 40 mg once daily in the evening
Number of subjects: 101
Study 3662274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 31848609 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole walnuts diet (WD; 57-99 g/d walnuts; 2.7% ALA)
Number of subjects: 42
Study 31848609 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut fatty acid-matched diet (WFMD; 2.6% ALA)
Number of subjects: 42
Study 31848609 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid replaces ALA diet (ORAD; 0.4% ALA)
Number of subjects: 42
Study 29122636 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 16791
Study 29122636 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 16791
Study 29122636 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a history of falling (both treatments)
Number of subjects: 16791
Study 29122636 — intervention group
Group type: COMPARATOR
Intervention: Apixaban vs Warfarin
Number of subjects: 16791
Study 28042631 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet cupping intervention (one session)
Number of subjects: 629
Study 28042631 — intervention group
Group type: COMPARATOR
Intervention: Control group (ordinary treatment only)
Number of subjects: 629
Study 25300690 — intervention group
Group type: EXPERIMENTAL
Intervention: L 1,2 group (N = 26)
Number of subjects: 87
Study 25300690 — intervention group
Group type: EXPERIMENTAL
Intervention: L 2,3 group (N = 29)
Number of subjects: 87
Study 25300690 — intervention group
Group type: COMPARATOR
Intervention: L 3,4 group (N = 27)
Number of subjects: 87
Study 23479319 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg sodium selenite and 30 mg/kg ascorbic acid every 24 h for 4 weeks
Number of subjects: 40
Study 20368052 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI) during OLT
Number of subjects: 31
Study 20368052 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 31
Study 18757284 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise (T‐EX)
Number of subjects: 71
Study 18757284 — intervention group
Group type: COMPARATOR
Intervention: Stretching (CON)
Number of subjects: 71
Study 16932894 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy plus pulse therapy (prednisolone, warfarin, dipyridamole, methylprednisolone pulse)
Number of subjects: 32
Study 16932894 — intervention group
Group type: COMPARATOR
Intervention: PWDM (prednisolone, warfarin, dipyridamole, mizoribine)
Number of subjects: 32
Study 16932894 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy plus pulse therapy
Number of subjects: 32
Study 16932894 — intervention group
Group type: COMPARATOR
Intervention: PWDM
Number of subjects: 32
Study 15590588 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision and hearing tests
Number of subjects: 208
Study 15590588 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision tests only
Number of subjects: 208
Study 15590588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing tests only
Number of subjects: 208
Study 15590588 — intervention group
Group type: COMPARATOR
Intervention: Neither
Number of subjects: 208
Study 10778867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid 20% with heparin (0.4 U/kg body weight/min)
Number of subjects: 8
Study 10778867 — intervention group
Group type: COMPARATOR
Intervention: Control infusion of saline (150 mmol/L)
Number of subjects: 8
Study 9068307 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physiotherapy (SPT)
Number of subjects: 20
Study 9068307 — intervention group
Group type: COMPARATOR
Intervention: Modified physiotherapy (MPT)
Number of subjects: 20
Study 8513615 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intrapartum monitoring
Number of subjects: 13000
Study 2871784 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol 100 to 400 mg/day
Number of subjects: 125
Study 2871784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 30380336 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-old patient condition
Number of subjects: 114
Study 30380336 — intervention group
Group type: COMPARATOR
Intervention: Middle-aged patient condition
Number of subjects: 114
Study 30938064 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP with heated humidification (ThermoSmart)
Number of subjects: 40
Study 30938064 — intervention group
Group type: COMPARATOR
Intervention: CPAP without heated humidification
Number of subjects: 40
Study 30938064 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for ThermoSmart ON
Number of subjects: 40
Study 29231498 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture therapy applied to Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6), Guanyuan (CV 4), Tianshu (ST 25) and Shuidao (ST 28), once a day, 5 times a week for 3 months
Number of subjects: 86
Study 29231498 — intervention group
Group type: COMPARATOR
Intervention: Healthcare guide and adjustment on diet and physical exercise
Number of subjects: 86
Study 25521911 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping strategies (expressing positive emotions, positive reframing of the cancer experience, cultivating a sense of peace and meaning)
Number of subjects: 281
Study 25521911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivating a sense of peace and meaning
Number of subjects: 281
Study 23461703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30
Study 23461703 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Listening
Number of subjects: 30
Study 23461703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) and Supportive Listening
Number of subjects: 30
Study 21226864 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warming
Number of subjects: 150
Study 21226864 — intervention group
Group type: COMPARATOR
Intervention: Standard care (sheet cover)
Number of subjects: 150
Study 18074229 — intervention group
Group type: EXPERIMENTAL
Intervention: Pearl barley with high beta-glucan content (7.0 g beta-glucan per day)
Number of subjects: 44
Study 18074229 — intervention group
Group type: COMPARATOR
Intervention: Rice (placebo group)
Number of subjects: 44
Study 16478760 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic oral contraceptives with 20, 30 or 50 microg/day estrogen
Number of subjects: 507
Study 15451891 — intervention group
Group type: EXPERIMENTAL
Intervention: Population management intervention using PopMan software by a nurse practitioner
Number of subjects: 3079
Study 15451891 — intervention group
Group type: EXPERIMENTAL
Intervention: Population management intervention
Number of subjects: 3079
Study 15451891 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control clinics)
Number of subjects: 3079
Study 11425369 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 425
Study 11425369 — intervention group
Group type: COMPARATOR
Intervention: Formula feeding
Number of subjects: 425
Study 8995739 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal biopsy
Number of subjects: 88
Study 8295082 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental nonprocedural talk (distraction)
Number of subjects: 42
Study 8295082 — intervention group
Group type: COMPARATOR
Intervention: Parental reassurance
Number of subjects: 42
Study 8295082 — intervention group
Group type: COMPARATOR
Intervention: Minimal‐treatment control
Number of subjects: 42
Study 3812339 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 35
Study 3812339 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial formula
Number of subjects: 35
Study 31777325 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Opioid Therapy (COT) tapering trial
Number of subjects: 190
Study 28347377 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Model of Resilience (PMR) intervention
Number of subjects: 53
Study 28347377 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 25569708 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.2 mg)
Number of subjects: 38
Study 25569708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 23544481 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric measures of leader self-complexity
Number of subjects: 103
Study 23544481 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative electroencephalogram (qEEG) profiles of leader self-complexity
Number of subjects: 103
Study 20651023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels in patients with OSA
Number of subjects: 75
Study 20651023 — intervention group
Group type: COMPARATOR
Intervention: Cysteine plasma levels in control subjects
Number of subjects: 75
Study 20651023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels in lean patients with OSA
Number of subjects: 75
Study 20651023 — intervention group
Group type: COMPARATOR
Intervention: Cysteine plasma levels in lean control subjects
Number of subjects: 75
Study 20651023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteine plasma levels after 6 months of CPAP therapy
Number of subjects: 75
Study 19556381 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 294
Study 19556381 — intervention group
Group type: COMPARATOR
Intervention: iodixanol
Number of subjects: 294
Study 17846331 — intervention group
Group type: EXPERIMENTAL
Intervention: TP10 (5 mg/kg dose as a 30-minute intravenous infusion before surgery)
Number of subjects: 297
Study 17846331 — intervention group
Group type: COMPARATOR
Intervention: Placebo (as a 30-minute intravenous infusion before surgery)
Number of subjects: 297
Study 17846331 — intervention group
Group type: EXPERIMENTAL
Intervention: TP10
Number of subjects: 297
Study 15077009 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1686
Study 12541863 — intervention group
Group type: EXPERIMENTAL
Intervention: Local group (local injected with IL‐2 + radiotherapy + chemotherapy)
Number of subjects: 90
Study 12541863 — intervention group
Group type: EXPERIMENTAL
Intervention: General group (ivdrip with IL‐2 + radiotherapy + chemotherapy)
Number of subjects: 90
Study 12541863 — intervention group
Group type: COMPARATOR
Intervention: Convention group (radiotherapy + chemotherapy)
Number of subjects: 90
Study 9555769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous beta-blocker administration
Number of subjects: 8326
Study 9555769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection fraction ≤ 40%
Number of subjects: 8326
Study 9555769 — intervention group
Group type: EXPERIMENTAL
Intervention: Killip class > I
Number of subjects: 8326
Study 9555769 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intravenous beta-blocker administration
Number of subjects: 8326
Study 9555769 — intervention group
Group type: COMPARATOR
Intervention: Oral beta-blocker therapy
Number of subjects: 8326
Study 9555769 — intervention group
Group type: COMPARATOR
Intervention: Nitrates and lisinopril treatment
Number of subjects: 8326
Study 7923668 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive head-up tilt at various angles (15 degrees, 30 degrees, 45 degrees, 60 degrees, 90 degrees)
Number of subjects: 22
Study 2499700 — intervention group
Group type: EXPERIMENTAL
Intervention: DPT - IPV (combined DPT - enhanced injectable polio vaccine)
Number of subjects: 200
Study 2499700 — intervention group
Group type: COMPARATOR
Intervention: DPT (Conventional Schedule with 3 doses of oral polio vaccine and 2 doses of DPT)
Number of subjects: 200
Study 2499700 — intervention group
Group type: EXPERIMENTAL
Intervention: DPT - IPV or DPT vaccine alone
Number of subjects: 200
Study 1097479 — intervention group
Group type: EXPERIMENTAL
Intervention: Benapryzine
Number of subjects: 10
Study 1097479 — intervention group
Group type: COMPARATOR
Intervention: Trihexyphenidyl
Number of subjects: 10
Study 30890102 — intervention group
Group type: EXPERIMENTAL
Intervention: Random biopsies (RB) + targeted biopsies (TB)
Number of subjects: 130
Study 30890102 — intervention group
Group type: COMPARATOR
Intervention: Only targeted biopsies (TB)
Number of subjects: 130
Study 28719572 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Aphasia Therapy (CIAT)
Number of subjects: 24
Study 28719572 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 24
Study 26405698 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe barbadensis Mill. Extract (AVH200®)
Number of subjects: 68
Study 26405698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 23203909 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping mesh (Parietene Progrip(®))
Number of subjects: 334
Study 23203909 — intervention group
Group type: COMPARATOR
Intervention: Sutured mesh
Number of subjects: 334